Manager, Network FP&A
- Employer
- Legend Biotech
- Location
- Bridgewater, New Jersey
- Posted date
- Oct 19, 2026
View more categories
- Discipline
- Administration, Accounting, Finance
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Pharm Country
By clicking apply, your email address will be shared with the employer.
Job Details
Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy through a portfolio of innovative technologies, including autologous, allogeneic, and in vivo cell therapy approaches. Our research spans chimeric antigen receptor T-cell (CAR-T), T-cell receptor (TCR-T), natural killer (NK) cell-based therapies, and other emerging platforms designed to transform the treatment of serious diseases. From our global network of research and development sites, we are committed to discovering and developing safe, effective, and cutting-edge therapies for patients worldwide.
Legend Biotech entered into a global collaboration agreement with Johnson & Johnson to jointly develop and commercialize CARVYKTI® (ciltacabtagene autoleucel; cilta-cel). Through this strategic partnership, we combine complementary expertise and capabilities to advance innovative immunotherapies for patients living with multiple myeloma.
Legend Biotech is seeking a Manager, Network FP&A as part of the Finance team based in Bridgewater, NJ.
Role Overview
The Manager, Network FP&A is responsible for financial planning, forecasting, performance management, and analytics across Legend Biotech’s global manufacturing and supply network. The role consolidates financial and
operational information across manufacturing sites, external manufacturing partners, and supply-chain functions to deliver an integrated view of performance, risks, and opportunities.
Financial Modeling and Decision Support
Develop and maintain financial models supporting capacity planning, network scenarios, product costing, gross-margin analysis, and operational decisions.
Support the Senior Manager, Network Finance & Strategy in evaluating manufacturing investments, automation initiatives, and make-versus-buy or sourcing alternatives.
Perform scenario and sensitivity analyses that clearly connect operational assumptions to COGM, profitability, cash flow, and other financial outcomes.
Performance Management and Reporting
Own consolidated monthly and quarterly reporting across the manufacturing and supply network, including actual-to-budget, forecast, prior-year, and long-range-plan comparisons.
Analyze COGM, cost per batch, productivity, volume, capacity, labor, overhead, external manufacturing, and gross-margin drivers.
Identify key risks, opportunities, trends, and required actions and communicate findings through concise, decision-oriented reporting.
Financial Modeling and Decision Support
Develop and maintain financial models supporting capacity planning, network scenarios, product costing, gross-margin analysis, and operational decisions.
Support the Senior Manager, Network Finance & Strategy in evaluating manufacturing investments, automation initiatives, and make-versus-buy or sourcing alternatives.
Perform scenario and sensitivity analyses that clearly connect operational assumptions to COGM, profitability, cash flow, and other financial outcomes.
Gross Margin and Network Competitiveness
Develop analytics supporting manufacturing productivity, cost competitiveness, and long-term gross margin expansion.
Consolidate and evaluate cross-site savings and productivity initiatives in partnership with Site Finance and operational leaders.
Track financial performance against approved initiatives and provide visibility into forecasted benefits, risks, timing, and execution gaps.
Portfolio Manufacturing Finance
Support financial planning and analysis for pipeline products as programs progress through development and toward commercialization.
Incorporate pipeline volumes, manufacturing costs, capacity needs, investment requirements, and sourcing assumptions into financial plans.
Partner with Finance and operational stakeholders to develop repeatable planning and reporting processes for new products.
KPI and Management Analytics
Own the development, maintenance, and continuous improvement of Network Finance dashboards, KPI reporting, and performance analytics.
Establish consistent metric definitions, assumptions, data sources, and reporting standards across sites and functions.
Develop clear executive-ready presentations that connect financial results with operational drivers and business implications.
Business Partnership
Partner with Manufacturing, Supply Chain, Quality, MSAT, Engineering, Procurement, Site Finance, and other stakeholders on financial planning and performance.
Provide timely analysis and financial insights that help business partners understand trade-offs, improve performance, and make informed decisions.
Build effective relationships across functions, sites, and regions while maintaining clear ownership, accountability, and follow-through.
Finance Transformation and Automation
Improve and standardize Network FP&A processes, planning models, reporting tools, and analytical methodologies.
Partner with Finance, IT, and data teams to automate reporting, strengthen data quality, and reduce manual data extraction and spreadsheet-intensive activities.
Support development of scalable data and analytics capabilities that improve forecast accuracy, reporting timeliness, and decision support.
The Manager, Network FP&A works closely with the Senior Manager, Network Finance & Strategy; Director, Supply Chain Finance; Raritan and Belgium Site Finance teams; Global Supply Chain Accounting; Corporate
FP&A; Commercial Finance; Manufacturing; Supply Chain; Quality; MSAT; Engineering; Procurement; Clinical Supply; IT; and data and analytics teams.
Requirements
Bachelor’s degree in Finance, Accounting, Business Administration, Economics, or a related field required.
Advanced degree and/or relevant professional accounting/finance qualification preferred.
Progressive experience in FP&A, manufacturing finance, supply-chain finance, corporate finance, or a related discipline.
Demonstrated experience with budgeting, forecasting, variance analysis, management reporting, and financial modeling.
Experience translating operational and commercial assumptions into financial plans and actionable business insights.
Manufacturing, biotechnology, pharmaceutical, cell-therapy, or other regulated-industry experience preferred.
Experience with ERP, enterprise planning, reporting, visualization, or analytics platforms preferred.
Strong FP&A, forecasting, financial-modeling, and analytical capabilities.
Understanding of manufacturing economics, including COGM, capacity, productivity, inventory, and gross-margin drivers.
Ability to integrate financial and operational data from multiple sites and functions.
Strong attention to detail while maintaining focus on the broader business narrative and decision.
Clear written and verbal communication skills, including executive-ready reporting and presentations.
Strong business-partnering, organizational, and project-management skills.
Ability to challenge assumptions constructively and manage multiple priorities in a dynamic environment.
Strong systems orientation and commitment to data quality, automation, standardization, and continuous improvement.
#Li-LB1
#Li-Hybrid
The base pay range below is what Legend Biotech USA Inc. reasonably expects to offer at the time of posting. Actual compensation may vary based on experience, skills, qualifications, and geographic location. The company reserves the right to modify this range as needed and in accordance with applicable laws.
Other Types of Pay: Performance-based bonus and/or equity is available to employees in eligible roles.
Benefits and Paid Time Off: Medical, dental, and vision insurance as well as a 401(k) retirement plan with a company match that vests fully on day one. We offer eight (8) weeks of paid parental leave after just three (3) months of employment, and a paid time off policy that includes vacation time, personal time, sick time, floating holidays, and eleven (11) company holidays. Additional voluntary benefits include flexible spending and health savings accounts, life and AD&D insurance, short- and long-term disability coverage, legal assistance, and supplemental plans such as pet, critical illness, accident, and hospital indemnity insurance. We also provide voluntary commuter benefits, family planning and care resources, well-being initiatives, and peer-to-peer recognition programs; demonstrating our ongoing commitment to building a culture where our people feel empowered, supported, and inspired to do their best work.
Pay Range (Base Pay):
$110,706 - $145,303 USD
Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech.
Work Authorization & Employment Eligibility
Applicants must be authorized to work in the United States. As part of our commitment to maintaining a lawful workforce and ensuring compliance with federal employment regulations, we participate in the E-Verify program. If you are selected for employment, you will be required to complete the Form I-9 process, and your employment eligibility will be verified through E-Verify in accordance with applicable federal law. We are committed to providing a fair, transparent, and welcoming hiring experience for all candidates.
EEO Statement
It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances.
Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company.
For information related to our privacy notice, please review: Legend Biotech Privacy Notice.
Company
Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and gene editing to take the leap.
For two years, Legend Biotech, then known as the “Legend Project,” operated in a room the size of a freight elevator, with the goal of creating a cell therapy for multiple myeloma, a hematological cancer that often relapses and can become refractory. The team produced nanobodies for single-domain antibody drugs and ultimately extended the half-life of the nanobodies with proprietary technologies.
In 2015, Legend’s scientists focused on research for chimeric antigen-receptor T-cells (CAR-T) targeting the BCMA protein, making the biotech one of the first companies in the world to engineer CAR-T cells for the BCMA protein. In 2016, investigator-initiated trials began in China.
In 2017, data from the trials were presented at the American Society for Clinical Oncology (ASCO), which led to a partnership with biopharmaceutical company Janssen Biotech, Inc. to co-develop the anti-BCMA CAR-T, ciltacabtagene autoleucel (cilta-cel). Applications seeking approval of cilta-cel for the treatment of patients with RRMM are currently under regulatory review by several health authorities around the world. CARVYKTI™ (ciltacabtagene autoleucel) was approved by the U.S. Food and Drug Administration in February 2022 and received conditional marketing approval from the European Medicines Agency in May 2022.
Today Legend Biotech is a global, commercial-stage company driven by a passion for patients. We continue to build our pipeline of cell therapy platforms, which includes CAR-T, CAR-NK, CAR-γδ T and non-gene-editing CAR technologies.
Our goal is to bring hope and opportunity to patients and their families by continuing to explore unique technologies.